Fucoidan

420 bookmarks
Custom sorting
Compositional Characteristics and In Vitro Evaluations of Antioxidant (...)
Compositional Characteristics and In Vitro Evaluations of Antioxidant (...)
Fucoidan, a fucose-containing sulfated polysaccharide with diverse biological functions, is mainly recovered from brown algae. In this study, we utilized a compressional-puffing process (CPP) to pretreat Sargassum crassifolium (SC) and extracted fucoidans from SC by warm water. Three fucoidan extracts (SC1: puffing at 0 kg/cm2; SC2: puffing at 1.7 kg/cm2; and SC3: puffing at 6.3 kg/cm2) were obtained, and their composition, and antioxidant and neuroprotective activities were examined. The results suggest that CPP decreased the bulk density of algal samples, expanded the algal cellular structures, and eliminated the unpleasant algal odor. The extraction yields of fucoidans were increased and impurities of fucoidans were decreased by increasing the pressures used in CPP. The SC1–SC3 extracts displayed various characteristics of fucoidan as illustrated by the analyses of composition, Fourier transform infrared (FTIR) spectroscopy, and molecular weight. All three extracts SC1–SC3 showed antioxidant activity dose-dependently. Although both SC1 and SC2 possessed high and similar neuronal protective properties, SC2 showed a higher extraction yield, higher efficacy in the reversion of H2O2-induced cytotoxicity in rat pheochromocytoma PC-12 cells, and lower impurities compared with SC1, and thus SC2 is suggested as a good candidate for a therapeutic agent in the preventive treatment of neurodegenerative diseases.
·mdpi.com·
Compositional Characteristics and In Vitro Evaluations of Antioxidant (...)
Crude Fucoidan Extracts Impair Angiogenesis in Models Relevant for Bon (...)
Crude Fucoidan Extracts Impair Angiogenesis in Models Relevant for Bon (...)
The marine origin polysaccharide fucoidan combines multiple biological activities. As demonstrated by various studies in vitro and in vivo, fucoidans show anti-viral, anti-tumor, anti-oxidant, anti-inflammatory and anti-coagulant properties, although the detailed molecular action remains to be eluci …
·ncbi.nlm.nih.gov·
Crude Fucoidan Extracts Impair Angiogenesis in Models Relevant for Bon (...)
Dietary fucoidan modulates the gut microbiota in mice by increasing th (...)
Dietary fucoidan modulates the gut microbiota in mice by increasing th (...)
Recently, fucoidan has been proposed as a potential prebiotic agent for functional food and pharmaceutical development. However, while previous studies illustrated favorable modulations of gut microbiota by fucoidan, changes in the overall microbial structure remain elusive. In the present study, modulations
·pubs.rsc.org·
Dietary fucoidan modulates the gut microbiota in mice by increasing th (...)
Dietary fucoidan of Acaudina molpadioides alter gut microbiota and mit (...)
Dietary fucoidan of Acaudina molpadioides alter gut microbiota and mit (...)
Cyclophosphamide (cy) is a widely used cancer drug. Many researchers have focused on the prevention and alleviation of its side effects, particularly damage to the intestinal mucosal barrier. In this study, we examined the effects of fucoidan, isolated from Acaudina molpadioides, on mice with intestinal muco
·pubs.rsc.org·
Dietary fucoidan of Acaudina molpadioides alter gut microbiota and mit (...)
Differences in cell death and cell cycle following fucoidan treatment (...)
Differences in cell death and cell cycle following fucoidan treatment (...)
Fucoidan, a sulfated polysaccharide present in marine brown seaweed, has been demonstrated to inhibit in vivo and in vitro growth of cells. The present study was conducted in HT‑29 human colon cancer cells cultured at a high density, and examined the potential underlying mechanisms by which fucoidan exerts its anti‑proliferative effects, which remain poorly understood. Fucoidan treatment of high‑density HT‑29 cells resulted in the inhibition of cell growth and increased apoptotic cell death. Flow cytometric analysis revealed that fucoidan treatment led to sub‑G1 phase cell cycle arrest. This was associated with decreased protein expression levels of Retinoblastoma protein and E2 factor protein. In conclusion, the results of the present study demonstrated that fucoidan possesses anticancer activity against high density HT‑29 cells by inhibiting cell growth and cell cycle progression.
·spandidos-publications.com·
Differences in cell death and cell cycle following fucoidan treatment (...)
Dr. Jennifer Kohler speaks about her research in intestinal fucose
Dr. Jennifer Kohler speaks about her research in intestinal fucose
Dr. Jennifer Kohler, Associate Professor at the University of Texas Southwestern Medical Center, speaks about her research in intestinal fucose. The Joint Webinar Series is a collaborative effort by GlycoNet and American Chemical Society's Carbohydrate Chemistry Division. The series is sponsored by New England Biolabs. To learn more, visit http://bit.ly/glycowebinar
·youtube.com·
Dr. Jennifer Kohler speaks about her research in intestinal fucose
Effect of fucoidan on ethanol-induced liver injury and steatosis in mice and the underlying mechanism Food & Nutrition Research
Effect of fucoidan on ethanol-induced liver injury and steatosis in mice and the underlying mechanism Food & Nutrition Research
Background: Alcoholic liver disease is caused as a result of chronic alcohol consumption. In this study, we used an alcoholic liver injury mouse model to investigate the effect of fucoidan on ethanol-induced liver injury and steatosis and the underlying mechanisms. Methods: All mice were randomly divided into four groups: 1) control group, 2) model group, 3) diammonium glycyrrhizinate treatment group (200 mg/kg body weight), and 4) fucoidan treatment group (300 mg/kg body weight). Administration of ethanol for 8 weeks induced liver injury and steatosis in mice. Results: Fucoidan treatment decreased serum alanine aminotransferase activity, serum total cholesterol levels, and hepatic triglyceride levels, and improved the morphology of hepatic cells. Fucoidan treatment upregulated the expression of AMPKα1, SIRT1, and PGC-1α and inhibited the expression of ChREBP and HNF-1α. The levels of hepatic IL-6 and IL-18 were significantly decreased in the fucoidan group. Further, the levels of cytochrome P450-2E1 (CYP2E1), glucose-regulated protein (GRP) 78, and 3-nitrotyrosine (3-NT) in hepatic tissues were reduced in the fucoidan group as compared to the model group. Fucoidan significantly reversed the reduction of ileac Farnesoid X receptor (FXR) and fibroblast growth factor 15 (FGF15) levels induced by alcohol- feeding and reduced CYP7A1 (cholesterol 7α-hydroxylase) expression and total bile acid levels in the liver tissue. In addition, fucoidan regulated the structure of gut flora, with increased abundance of Prevotella and decreased abundance of Paraprevotella and Romboutsia as detected by 16S rDNA high-throughput sequencing. Conclusion: Fucoidan inhibited alcohol-induced steatosis and disorders of bile acid metabolism in mice through the AMPKα1/SIRT1 pathway and the gut microbiota–bile acid–liver axis and protected against alcohol- induced liver injury in vivo.
·foodandnutritionresearch.net·
Effect of fucoidan on ethanol-induced liver injury and steatosis in mice and the underlying mechanism Food & Nutrition Research
Effects of fucoidan and chemotherapeutic agent combinations on maligna (...)
Effects of fucoidan and chemotherapeutic agent combinations on maligna (...)
Fucoidan is an effective antitumor agent, either alone or in combination with cisplatin, doxorubicin and taxol in MCF-7 breast cancer cells. Drug combinations that discriminate between cancerous and non-cancerous cells afford a plausible and viable strategy of attaining therapeutic efficacy and avoi …
·ncbi.nlm.nih.gov·
Effects of fucoidan and chemotherapeutic agent combinations on maligna (...)
Effects of fucoidan from Fucus vesiculosus in reducing symptoms of ost (...)
Effects of fucoidan from Fucus vesiculosus in reducing symptoms of ost (...)
Preliminary investigation of a fucoidan with demonstrated reduction in the symptoms of osteoarthritis (OA) of the hip and knee.A double-blind randomized controlled trial was carried out to determine the safety and efficacy of a 300 mg dose of a Fucus ...
·ncbi.nlm.nih.gov·
Effects of fucoidan from Fucus vesiculosus in reducing symptoms of ost (...)
Effects of Laminaria Japonica Polysaccharides on the Survival of Non-Small-Cell Lung Cancer A549 Cells
Effects of Laminaria Japonica Polysaccharides on the Survival of Non-Small-Cell Lung Cancer A549 Cells
Objective. To investigate the effect of Laminaria japonica polysaccharides (LJP) on the survival of non-small-cell lung cancer (NSCLC) A549 cells and its mechanism. Methods. In vitro: the cells were randomly divided into control group, LJP (5 mg/ml) group, LJP (10 mg/ml) group, and LJP (20 mg/ml) group. After corresponding treatment, the survival rate and the expression of proteins related to proliferation, apoptosis, epithelial-mesenchymal transition (EMT), and signaling pathway were detected by CCK8 assay and Western blot, respectively. In vivo: a xenograft model was established to detect the tumor volume and mass and the expression of the above pathway proteins. Results. Compared with the control group, LJP decreased the survival rate of A549 cells (), inhibited the protein expression of Ki67 and PCNA (), downregulated the expression of Bcl-2 while upregulated the expression of Bax, cl-caspase-3, and cl-caspase-9 (), upregulated the expression of E-cadherin, downregulated the expression of vascular endothelial growth factor (VEGF) and N-cadherin (), and downregulated β-catenin, transcription factor-4 (TCF4), and c-Myc protein expression levels (). In vivo: LJP decreased the volume and mass of the xenograft tumors and downregulated β-catenin, TCF4, and c-Myc protein expression levels compared with the control group (). Conclusion. LJP can inhibit the survival of non-small-cell lung cancer A549 cells in vitro, and its mechanism is related to the inhibition of activation of β-catenin/TCF4 pathway activation.
·hindawi.com·
Effects of Laminaria Japonica Polysaccharides on the Survival of Non-Small-Cell Lung Cancer A549 Cells
Epigenetic Modification and Differentiation Induction of Malignant Glioma Cells by Oligo-Fucoidan. - PubMed - NCBI
Epigenetic Modification and Differentiation Induction of Malignant Glioma Cells by Oligo-Fucoidan. - PubMed - NCBI
Malignant glioma (MG) is a poor prognostic brain tumor with inevitable recurrence after multimodality treatment. Searching for more effective treatment is urgently needed. Differentiation induction via epigenetic modification has been proposed as a potential anticancer strategy. Natural products are …
·ncbi.nlm.nih.gov·
Epigenetic Modification and Differentiation Induction of Malignant Glioma Cells by Oligo-Fucoidan. - PubMed - NCBI
Evaluation of bioactivity of fucoidan from laminaria with in vitro hum (...)
Evaluation of bioactivity of fucoidan from laminaria with in vitro hum (...)
Background: Seaweeds represent one of the few remaining food sources available globally which are not being fully utilized or even over utilized. Kelps ( Laminaria spp. ) are one of the numerous species of brown seaweeds, a popular marine vegetable, which has been used as a source of iodine and minerals for centuries. Kelps contain anionic polysaccharides called fucoidans heteroglycans with L – fucose units. Their monosaccharide composition, physicochemical and bioactive properties vary between seaweed species. The objective of this work was to evaluate the bioactive properties of laminaria fucoidan ( L. digitata and L. hyperborea ) toward THP–1 macrophages, a human macrophage like cell line, and investigate its potential antioxidant and immunomodulatory characteristics. Methods: THP-1 macrophages were incubated with five fucoidan concentrations. The Oxygen Radical Absorbance Capacity (ORAC) assay was determined for cell lysates and for the fucoidan extract, in addition to Total Polyphenol Content (TPC). Cytotoxicity of fucoidan was assessed by light microscopy, followed by XTT proliferation assay. Enzyme–linked immunosorbant assays (ELISA) were performed to determine concentrations of the secreted tumor necrosis factor α (TNF-α), interleukin 6 (IL–6), and interleukin 10 (IL–10).   Results: Fucoidan did not affect macrophage ability to scavenge oxygen radicals (ORAC) confirming its antioxidant properties toward activated macrophages. The laminaria fucoidan extract at 100 µg/ml concentration lowered macrophage viability. Lower concentrations of laminaria fucoidan did not have impact on cell viability. Very low concentration of fucoidan at 0.1 µg/ml triggered secretion of TNF-α. However, IL–6 and interleukin IL–10 were expressed when concentration of applied fucoidan was 10 µg/ml indicating bioactivity of laminaria fucoidan through immunomodulatory actions. Conclusions: The study demonstrated how laminaria fucoidan may have bioactive properties towards THP–1 macrophages. Changes in cytokine secretion between pro–inflammatory (TNF–α, and IL–6) and anti–inflammatory (IL–10) cytokines confirmed bioactivity of the laminaria fucoidan extracts. Keywords: Seaweeds, Kelps, Laminaria, fucoidan, bioactivity, macrophages
·ffhdj.com·
Evaluation of bioactivity of fucoidan from laminaria with in vitro hum (...)
Frontiers Biomedical potential of fucoidan a seaweed sulfated polysac (...)
Frontiers Biomedical potential of fucoidan a seaweed sulfated polysac (...)
Frontiers Events is a rapidly growing calendar management system dedicated to the scheduling of academic events. This includes announcements and invitations, participant listings and search functionality, abstract handling and publication, related events and post-event exchanges. Whether an organizer or participant, make your event a Frontiers Event!
·frontiersin.org·
Frontiers Biomedical potential of fucoidan a seaweed sulfated polysac (...)
Frontiers Effects of the Brown Seaweed Laminaria japonica Supplementa (...)
Frontiers Effects of the Brown Seaweed Laminaria japonica Supplementa (...)
The intestinal microbial communities play critical roles in various aspects of body function of the host. Prebiotics, such as dietary fiber, can affect health of the host by altering the composition of intestinal microbiota. Although brown seaweed Laminaria japonica is rich in dietary fiber, studies on its prebiotic potential are quite rare. In this study, basal diet (control), basal diet supplemented with dried L. japonica (DLJ), heat-treated dried L. japonica (HLJ), or heated dried L. japonica with added fructooligosaccharide (FHLJ) was fed to rats for 16 weeks. Serum concentrations of IgG, triglyceride, and cholesterol were measured. In addition, the intestinal microbiota composition was analyzed by high-throughput sequencing of 16S rRNA gene. As compared to the control group, DLJ, HLJ, and FHLJ groups showed significantly higher serum IgG concentration, but had lower weight gain and serum triglyceride concentration. Moreover, DLJ, HLJ, and FHLJ groups showed lower Fimicutes to Bacteroidetes ratio when compared with the control group. As compared with the control group, obesity-associated bacterial genera (Allobaculum, Turicibacter, Coprobacillus, Mollicute, and Oscilibacter), and the genera with pathogenic potentials (Mollicute, Bacteroides, Clostridium, Escherichia, and Prevotella) decreased while leanness-associated genera (Alistipes, Bacteroides, and Prevotella), and lactic acid bacterial genera (Subdoligranulum, Streptococcus, Lactobacillus, Enterococcus, and Bifid...
·frontiersin.org·
Frontiers Effects of the Brown Seaweed Laminaria japonica Supplementa (...)
Fucoidan (FUC) and galactooligosaccharides (GOS) ameliorate high-fat-diet-induced dyslipidemia in rats by modulating the gut microbiota and bile acid metabolism - ScienceDirect
Fucoidan (FUC) and galactooligosaccharides (GOS) ameliorate high-fat-diet-induced dyslipidemia in rats by modulating the gut microbiota and bile acid metabolism - ScienceDirect
Dyslipidemia is an important risk factor for cardiovascular diseases. Fucoidan (FUC) is a polysaccharide extracted from brown marine algae with variou…
·sciencedirect.com·
Fucoidan (FUC) and galactooligosaccharides (GOS) ameliorate high-fat-diet-induced dyslipidemia in rats by modulating the gut microbiota and bile acid metabolism - ScienceDirect